Evidence map›Paper›PMID 33619662›Full record

ArticleMolecular biology reports2021

Impact of Reck expression and promoter activity in neuronal in vitro differentiation.

Marina Trombetta-Lima, Thais Assis-Ribas, Ricardo C Cintra, Joana D Campeiro, Juliano R Guerreiro, Sheila M B Winnischofer, Isis C C Nascimento, Henning Ulrich, Mirian A F Hayashi, Mari C Sogayar

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. TwoGenes · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Marina Trombetta-LimaNúcleo de Terapia Celular e Molecular (NUCEL), Faculdade de Medicina, Universidade de São Paulo (USP), Rua Pangaré, 100 (Cidade Universitária), São Paulo, SP, 05360-130, Brazil.
Thais Assis-RibasNúcleo de Terapia Celular e Molecular (NUCEL), Faculdade de Medicina, Universidade de São Paulo (USP), Rua Pangaré, 100 (Cidade Universitária), São Paulo, SP, 05360-130, Brazil.
Ricardo C CintraDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo (USP), São Paulo, SP, 05508-000, Brazil.
Joana D CampeiroDepartamento de Farmacologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de Maio 100, Ed INFAR, 3º andar, São Paulo, SP, 04044-020, Brazil.
Juliano R GuerreiroFaculdade de Farmácia, Universidade Paulista (UNIP), São Paulo, SP, 05347-020, Brazil.
Sheila M B WinnischoferDepartamento de Bioquímica e Biologia Molecular, Universidade Federal do Paraná (UFPR), Curitiba, PR, 81531-990, Brazil.
Isis C C NascimentoDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo (USP), São Paulo, SP, 05508-000, Brazil.
Henning UlrichDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo (USP), São Paulo, SP, 05508-000, Brazil.
Mirian A F HayashiDepartamento de Farmacologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), Rua 3 de Maio 100, Ed INFAR, 3º andar, São Paulo, SP, 04044-020, Brazil. mhayashi@unifesp.br.
Mari C SogayarNúcleo de Terapia Celular e Molecular (NUCEL), Faculdade de Medicina, Universidade de São Paulo (USP), Rua Pangaré, 100 (Cidade Universitária), São Paulo, SP, 05360-130, Brazil. mcsoga@iq.usp.br.ORCID http://orcid.org/0000-0003-4805-4609
Universidade de São Paulo · BRUniversidade Federal de São Paulo · BRUniversidade Federal do Paraná · BRUniversidade Paulista · BR

Funding

Banco Nacional de Desenvolvimento Econômico e Social (BR) 09.2.1066.1Conselho Nacional de Desenvolvimento Científico e Tecnológico 306392/2017-8Conselho Nacional de Desenvolvimento Científico e Tecnológico 3118/2015-6Conselho Nacional de Desenvolvimento Científico e Tecnológico 401430/2013-8Conselho Nacional de Desenvolvimento Científico e Tecnológico 409960/2013-6Conselho Nacional de Desenvolvimento Científico e Tecnológico 426896/2016-5Conselho Nacional de Desenvolvimento Científico e Tecnológico 454234/2014-7Conselho Nacional de Desenvolvimento Científico e Tecnológico 455953/2014-7Conselho Nacional de Desenvolvimento Científico e Tecnológico 457601/2013-2Conselho Nacional de Desenvolvimento Científico e Tecnológico 465656/2014-5Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88881.068070/2014-01Financiadora de Estudos e Projetos 01.08.0484.00Financiadora de Estudos e Projetos 01.08.0622.05Financiadora de Estudos e Projetos 51634-1ADFundação de Amparo à Pesquisa do Estado de São Paulo 016/05311-2Fundação de Amparo à Pesquisa do Estado de São Paulo 2012/50880-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/50891-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2015/26328-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/18277-7Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/02413-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/07366-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/20014-0
6 · The paper itself

Abstract

Reck (REversion-inducing Cysteine-rich protein with Kazal motifs) tumor suppressor gene encodes a multifunctional glycoprotein which inhibits the activity of several matrix metalloproteinases (MMPs), and has the ability to modulate the Notch and canonical Wnt pathways. Reck-deficient neuro-progenitor cells undergo precocious differentiation; however, modulation of Reck expression during progression of the neuronal differentiation process is yet to be characterized. In the present study, we demonstrate that Reck expression levels are increased during in vitro neuronal differentiation of PC12 pheochromocytoma cells and P19 murine teratocarcinoma cells and characterize mouse Reck promoter activity during this process. Increased Reck promoter activity was found upon induction of differentiation in PC12 cells, in accordance with its increased mRNA expression levels in mouse in vitro models. Interestingly, Reck overexpression, prior to the beginning of the differentiation protocol, led to diminished efficiency of the neuronal differentiation process. Taken together, our findings suggest that increased Reck expression at early stages of differentiation diminishes the number of neuron-like cells, which are positive for the beta-3 tubulin marker. Our data highlight the importance of Reck expression evaluation to optimize in vitro neuronal differentiation protocols.

Indexed as

Genes, Tumor SuppressorAnimalsBinding SitesFlow CytometryGene Expression Regulation, NeoplasticGPI-Linked ProteinsMiceNeurogenesisPC12 CellsPromoter Regions, GeneticRatsReal-Time Polymerase Chain ReactionTeratocarcinomaTubulinUp-Regulationbeta3 tubulin, mouseGPI-Linked ProteinsReck protein, mouseTubulinNeuronal differentiationP19 teratocarcinomaPC12 pheochromocytomaReck promoter activityReck tumor suppressor gene

Identifiers

PMID33619662
OpenAlexW3129918813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.